NCT03455556 2023-01-06Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung CancerMayo ClinicPhase 1 Terminated1 enrolled 1 chart
NCT02639091 2019-11-07Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid TumorsBayerPhase 1 Completed36 enrolled